William D. Baird III
2012
In 2012, William D. Baird III earned a total compensation of $1.1M as Chief financial officer at Amicus Therapeutics.
Compensation breakdown
| Bonus | $152,450 |
|---|---|
| Option Awards | $698,826 |
| Salary | $225,000 |
| Other | $9,380 |
| Total | $1,085,656 |
Baird received $698.8K in option awards, accounting for 64% of the total pay in 2012.
Baird also received $152.5K in bonus, $225K in salary and $9.4K in other compensation.
Rankings
In 2012, William D. Baird III's compensation ranked 5,798th out of 11,487 executives tracked by ExecPay. In other words, Baird earned more than 49.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,798 out of 11,487 | 50th |
Division Manufacturing | 2,058 out of 4,253 | 52nd |
Major group Chemicals And Allied Products | 510 out of 1,198 | 57th |
Industry group Drugs | 345 out of 920 | 63rd |
Industry Pharmaceutical Preparations | 271 out of 700 | 61st |
Source: SEC filing on April 28, 2015.
Baird's colleagues
We found five more compensation records of executives who worked with William D. Baird III at Amicus Therapeutics in 2012.
2012
John Crowley
Amicus Therapeutics
Chief Executive Officer
2012
David Lockhart
Amicus Therapeutics
Chief Scientific Officer
2012
Bradley Campbell
Amicus Therapeutics
Chief Operating Officer
2012
Pol Boudes
Amicus Therapeutics
Chief Medical Officer
2012
Daphne Quimi
Amicus Therapeutics